VCEL - Vericel Corporation
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.45
|
Rev Est: $92.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.00
DETAILS
HIGH:
$45.00
LOW:
$45.00
MEDIAN:
$45.00
CONSENSUS:
$45.00
UPSIDE:
17.65%
Market Cap:
1.93B
Volume:
440,470
Avg Volume:
546,753
52 Week Range:
29.24-55.41
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.23
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
357
IPO Date:
1997-02-04
EPS (TTM):
0.21
P/E Ratio:
258.85
Revenue (TTM):
237.22M
Total Assets:
432.72M
Total Debt:
98.85M
Cash & Equiv:
74.52M
Rev Growth (5Y):
15.0%
EPS Growth (5Y):
35.0%
FCF Growth (5Y):
N/A
ROCE:
2.9%
Debt/Equity:
0.34
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.10 | $-0.02 | +600.0% | $67.5M | $92.7M | -27.2% |
| 2025-07-31 | $-0.01 | $-0.04 | +75.0% | $63.2M | $64.6M | -2.1% |
| 2025-05-08 | $-0.23 | $-0.09 | -155.6% | $52.6M | $64.8M | -18.8% |
| 2025-02-27 | $0.38 | $0.31 | +22.6% | $75.4M | $58.1M | +29.7% |
| 2024-11-07 | $-0.02 | $-0.05 | +60.0% | $57.9M | $78.0M | -25.7% |
| 2024-08-01 | $-0.10 | $-0.10 | 0.0% | $52.7M | $55.2M | -4.6% |
| 2024-05-08 | $-0.08 | $-0.11 | +27.3% | $51.3M | $49.1M | +4.5% |
| 2024-02-29 | $0.26 | $0.17 | +52.9% | $65.0M | $63.9M | +1.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 237.22M | 197.52M | 164.37M | 156.18M | 124.18M | 117.85M | 90.86M | 63.92M | 54.38M | 51.17M | 28.80M | 19,000 |
| Net Income | 10.36M | (3.18M) | (16.71M) | (7.47M) | 2.86M | (9.66M) | (8.14M) | (17.29M) | (19.57M) | (16.34M) | (19.92M) | (15.62M) |
| EPS | 0.21 | -0.07 | -0.35 | -0.16 | 0.06 | -0.18 | -0.20 | -0.52 | -0.85 | -0.69 | -1.71 | -5.18 |
| Total Assets | 432.72M | 353.66M | 273.00M | 243.71M | 205.61M | 153.24M | 118.69M | 54.58M | 48.60M | 34.31M | 47.58M | 9.21M |
| Total Debt | 98.85M | 88.04M | 47.57M | 50.18M | 53.30M | 27.85M | 0 | 17.24M | 10.13M | 71,000 | 109,000 | 6,000 |
| Cash & Equivalents | 74.52M | 69.09M | 51.07M | 68.33M | 33.62M | 26.89M | 18.29M | 26.86M | 22.98M | 14.58M | 30.34M | 8.06M |
| Operating Cash Flow | 58.16M | 35.31M | 17.69M | 29.04M | 17.57M | (7.18M) | (412,000) | (13.18M) | (19.89M) | (13.35M) | (25.41M) | (19.94M) |
| Free Cash Flow | (5.81M) | 7.80M | 10.09M | 21.12M | 14.95M | (9.80M) | (3.09M) | (14.69M) | (21.31M) | (15.77M) | (26.24M) | (19.98M) |
| FCF per Share | -0.12 | 0.16 | 0.21 | 0.45 | 0.33 | -0.22 | -0.08 | -0.44 | -0.92 | -0.66 | -2.25 | -6.63 |
| Book Value | 291.97M | 225.95M | 192.27M | 170.46M | 134.26M | 111.09M | 102.23M | 22.54M | 24.71M | 22.13M | 35.64M | 3.89M |
| Cash & ST Investments | 116.21M | 109.56M | 119.54M | 103.40M | 75.81M | 69.72M | 82.92M | 26.86M | 22.98M | 14.58M | 30.34M | 8.06M |
| ROC Equity | 0.04 | -0.01 | -0.09 | -0.04 | 0.02 | -0.09 | -0.08 | -0.77 | -0.79 | -0.74 | -0.56 | -4.01 |